Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Journal of Animal Science
|
July 1, 1995
Performance, carcass yield, and carcass quality characteristics of steers finished on rhizoma peanut (Arachis glabrata)-tropical grass pasture or concentrate
L L Bennett, A C Hammond, M J Williams, et al.
Molecular Pharmacology
|
June 1, 1985
Inhibition of utilization of hypoxanthine and guanine in cells treated with the carbocyclic analog of adenosine. Phosphates of carbocyclic nucleoside analogs as inhibitors of hypoxanthine (guanine) phosphoribosyltransferase
L L Bennett, R W Brockman, L M Rose, et al.
Antimicrobial Agents and Chemotherapy
|
May 21, 1998
Metabolism in human cells of the D and L enantiomers of the carbocyclic analog of 2'-deoxyguanosine: substrate activity with deoxycytidine kinase, mitochondrial deoxyguanosine kinase, and 5'-nucleotidase
L L Bennett, P W Allan, G Arnett, et al.
Biochemical Pharmacology
|
August 15, 1981
Biological activities and modes of action of 9-alpha-D-arabinofuranosyladenine and 9-alpha-D-arabinofuranosyl-8-azaadenine
L L Bennett, P W Allan, S C Shaddix, et al.
Molecular Pharmacology
|
March 3, 1999
Comparison of the mechanism of cytotoxicity of 2-chloro-9-(2-deoxy-2- fluoro-beta-D-arabinofuranosyl)adenine, 2-chloro-9-(2-deoxy-2-fluoro- beta-D-ribofuranosyl)adenine, and 2-chloro-9-(2-deoxy-2,2-difluoro- beta-D-ribofuranosyl)adenine in CEM cells
W B Parker, S C Shaddix, L M Rose, et al.
Molecular Pharmacology
|
February 11, 1992
Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus
W B Parker, S C Shaddix, P W Allan, et al.
Molecular Pharmacology
|
December 1, 1993
Phosphorylation of the enantiomers of the carbocyclic analog of 2'-deoxyguanosine in cells infected with herpes simplex virus type 1 and in uninfected cells. Lack of enantiomeric selectivity with the viral thymidine kinase
L L Bennett, W B Parker, P W Allan, et al.
Cancer Research
|
May 11, 1991
Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate
W B Parker, S C Shaddix, C H Chang, et al.
Human Gene Therapy
|
October 10, 1997
In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase
W B Parker, S A King, P W Allan, et al.
Nucleosides & Nucleotides
|
August 5, 1999
Gene therapy of cancer: activation of nucleoside prodrugs with E. coli purine nucleoside phosphorylase
J A Secrist, W B Parker, P W Allan, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Journal of Animal Science
|
July 1, 1995
Performance, carcass yield, and carcass quality characteristics of steers finished on rhizoma peanut (Arachis glabrata)-tropical grass pasture or concentrate
L L Bennett, A C Hammond, M J Williams, et al.
Molecular Pharmacology
|
June 1, 1985
Inhibition of utilization of hypoxanthine and guanine in cells treated with the carbocyclic analog of adenosine. Phosphates of carbocyclic nucleoside analogs as inhibitors of hypoxanthine (guanine) phosphoribosyltransferase
L L Bennett, R W Brockman, L M Rose, et al.
Antimicrobial Agents and Chemotherapy
|
May 21, 1998
Metabolism in human cells of the D and L enantiomers of the carbocyclic analog of 2'-deoxyguanosine: substrate activity with deoxycytidine kinase, mitochondrial deoxyguanosine kinase, and 5'-nucleotidase
L L Bennett, P W Allan, G Arnett, et al.
Biochemical Pharmacology
|
August 15, 1981
Biological activities and modes of action of 9-alpha-D-arabinofuranosyladenine and 9-alpha-D-arabinofuranosyl-8-azaadenine
L L Bennett, P W Allan, S C Shaddix, et al.
Molecular Pharmacology
|
March 3, 1999
Comparison of the mechanism of cytotoxicity of 2-chloro-9-(2-deoxy-2- fluoro-beta-D-arabinofuranosyl)adenine, 2-chloro-9-(2-deoxy-2-fluoro- beta-D-ribofuranosyl)adenine, and 2-chloro-9-(2-deoxy-2,2-difluoro- beta-D-ribofuranosyl)adenine in CEM cells
W B Parker, S C Shaddix, L M Rose, et al.
Molecular Pharmacology
|
February 11, 1992
Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus
W B Parker, S C Shaddix, P W Allan, et al.
Molecular Pharmacology
|
December 1, 1993
Phosphorylation of the enantiomers of the carbocyclic analog of 2'-deoxyguanosine in cells infected with herpes simplex virus type 1 and in uninfected cells. Lack of enantiomeric selectivity with the viral thymidine kinase
L L Bennett, W B Parker, P W Allan, et al.
Cancer Research
|
May 11, 1991
Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate
W B Parker, S C Shaddix, C H Chang, et al.
Human Gene Therapy
|
October 10, 1997
In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase
W B Parker, S A King, P W Allan, et al.
Nucleosides & Nucleotides
|
August 5, 1999
Gene therapy of cancer: activation of nucleoside prodrugs with E. coli purine nucleoside phosphorylase
J A Secrist, W B Parker, P W Allan, et al.
Page
of 9